2796.T
Pharmarise Holdings Corporation
スタンダード · 小売業 · 小売 · JP
JPY 506.00
+0.20%Year over year
Reported trailing growth
- Revenue
- +11.8%
- EBITDA
- —
- EBIT
- +441.2%
- EPS
- +87.2%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -1.0%
- EBITDA
- —
- EPS
- +346.6%
Three-year CAGR
- Revenue
- +7.2%
- EBITDA
- -21.7%
- EBIT
- -42.2%
- Net income
- -4.6%
- EPS
- +2.8%
- Free cash flow
- +26.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Feb 1, 2026